论文部分内容阅读
我国新《专利法》已于2009年10月1日正式生效。新《专利法》中涉及到医药行业的相关修改包括专利授权门槛提高、确立平行进口的合法地位、扩大侵权例外情形、明确强制许可出口、保护生物遗传资源、明确专利权共有人权利的行使等多个方面。本文分析了专利法的修改内容,着重于其对我国制药行业的积极影响或限制,以期促进我国制药行业更好地理解和运用新《专利法》,维护我国制药产业健康有序地发展。
China’s new “Patent Law” was October 1, 2009 came into effect. Related changes in the new Patent Law involving the pharmaceutical industry include raising the threshold for patent licensing, establishing the legal status of parallel imports, expanding the exception to infringement, explicitly forcibly exporting, protecting biological genetic resources, clarifying the exercise of the rights of the patent owner Many aspects. This article analyzes the amendment content of the patent law, focusing on its positive influence or restriction on the pharmaceutical industry in our country, in order to promote the pharmaceutical industry in our country to better understand and use the new “Patent Law” to safeguard the healthy and orderly development of China’s pharmaceutical industry.